Patents by Inventor Wen Feng ZENG

Wen Feng ZENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Application of naringenin and naringin in tumor radiotherapy
    Patent number: 10307393
    Abstract: The present invention provides applications of a small molecular flavonoid compound in preparing a medication for sensitizing/synergizing tumor radiation therapy as well as reducing radioactive damage. The small molecular flavonoid compound can be naringenin, hesperetin, luteolin and apigenin, etc. The medication contains a small molecular flavonoid compound and a plurality of conventional pharmaceutical additives; wherein the small molecular flavonoid compound is an active ingredient.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: June 4, 2019
    Assignees: INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES, TOPFOND PHARMACEUTICAL CO., LTD.
    Inventors: Wei Liang, Chun Ling Zhang, Wen Feng Zeng, Chao Zhang, Luo Yang Wang
  • APPLICATION OF NARINGENIN AND NARINGIN IN TUMOR RADIOTHERAPY
    Publication number: 20180200223
    Abstract: The present invention provides applications of a small molecular flavonoid compound in preparing a medication for sensitizing/synergizing tumor radiation therapy as well as reducing radioactive damage. The small molecular flavonoid compound can be naringenin, hesperetin, luteolin and apigenin, etc. The medication contains a small molecular flavonoid compound and a plurality of conventional pharmaceutical additives; wherein the small molecular flavonoid compound is an active ingredient.
    Type: Application
    Filed: August 25, 2016
    Publication date: July 19, 2018
    Applicant: INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES
    Inventors: Wei LIANG, Chun Ling ZHANG, Wen Feng ZENG, Chao ZHANG, Luo Yang WANG